\-\ Texto\\:\\ \ \(0\)\
\-\ negative\\ for\\ focal\\ neurological\\ findings\ \(0\)\
\-\ negative\\ eeg\ \(0\)\
\-\ vp\\ shunt\ \(0\)\
\-\ chemotherapy\ \(327\)\
\-\ patient\\ died\\ 4\\ months\\ after\\ presentation\ \(0\)\
\-\ \\â\\€\\¢\\ large\\ frond\\-like\\ intraventicular\\ mass\\,\\ right\\ trigone\ \(0\)\
\-\ \\â\\€\\¢\\ marked\\ hydrodrocephalus\ \(0\)\
\-\ \\â\\€\\¢\\ mass\\ enhances\\ homogeneously\\ with\\ contrast\ \(0\)\
\-\ \\â\\€\\¢\\ dandy\\-walker\\ variant\ \(0\)\
\-\ atypical\\ teratoid\\/rhabdoid\\ tumor\ \(1\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ papilloma\ \(4\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ carcinoma\ \(1\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ \\â\\€\\¢\\ pnet\ \(0\)\
\-\ \\â\\€\\¢\\ at\\-rt\\ \\(atypical\\ teratoid\\/rhabdoid\\ tumor\\)\ \(0\)\
\-\ 4\\ month\\ old\\ girl\\ brought\\ to\\ er\\ with\\ projectile\\ vomiting\\.\\ evaluated\\ for\\ gastroenteritis\\.\\ \\ returned\\ to\\ er\\ 1\\ week\\ later\\ with\\ dehydration\\ and\\ seizure\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.16789439481384513\ \(0\)\
\-\ teratoid\\/rhabdoid\\:\\ 0\\.16356210178359962\ \(0\)\
\-\ hydrodrocephalus\\:\\ 0\\.10494664790436307\ \(0\)\
\-\ at\\-rt\\:\\ 0\\.10494664790436307\ \(0\)\
\-\ choroid\\:\\ 0\\.10383740780269024\ \(0\)\
\-\ plexus\\:\\ 0\\.09885903166320074\ \(0\)\
\-\ intraventicular\\:\\ 0\\.09186793018212366\ \(0\)\
\-\ atypical\\:\\ 0\\.08817930084785607\ \(0\)\
\-\ frond\\-like\\:\\ 0\\.08178105089179981\ \(0\)\
\-\ er\\:\\ 0\\.07805200373685622\ \(0\)\
\-\ dandy\\-walker\\:\\ 0\\.07640027560914438\ \(0\)\
\-\ trigone\\:\\ 0\\.07536442588307735\ \(0\)\
\-\ vp\\:\\ 0\\.07121791761797955\ \(0\)\
\-\ eeg\\:\\ 0\\.0698938029142864\ \(0\)\
\-\ gastroenteritis\\:\\ 0\\.0698938029142864\ \(0\)\
\-\ dehydration\\:\\ 0\\.0698938029142864\ \(0\)\
\-\ projectile\\:\\ 0\\.06711267373355419\ \(0\)\
\-\ pnet\\:\\ 0\\.06164205076476324\ \(0\)\
\-\ negative\\:\\ 0\\.06076476574702081\ \(0\)\
\-\ died\\:\\ 0\\.05962923731185927\ \(0\)\
\-\ homogeneously\\:\\ 0\\.059367583660445276\ \(0\)\
\-\ 4\\:\\ 0\\.05668980726616774\ \(0\)\
\-\ brought\\:\\ 0\\.05525156135798643\ \(0\)\
\-\ shunt\\:\\ 0\\.052631777015405466\ \(0\)\
\-\ returned\\:\\ 0\\.05205794246995454\ \(0\)\
\-\ papilloma\\:\\ 0\\.05111583151092212\ \(0\)\
\-\ variant\\:\\ 0\\.04845936066194343\ \(0\)\
\-\ enhances\\:\\ 0\\.04805232060541629\ \(0\)\
\-\ tumor\\:\\ 0\\.04743410241930503\ \(0\)\
\-\ evaluated\\:\\ 0\\.046639031238280795\ \(0\)\
\-\ ependymoma\\:\\ 0\\.04553673615699716\ \(0\)\
\-\ seizure\\:\\ 0\\.044982926447057967\ \(0\)\
\-\ neurological\\:\\ 0\\.04401815013749694\ \(0\)\
\-\ marked\\:\\ 0\\.03970094643600603\ \(0\)\
\-\ vomiting\\:\\ 0\\.038839986179105716\ \(0\)\
\-\ later\\:\\ 0\\.03673117429753481\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.03646364029929601\ \(0\)\
\-\ girl\\:\\ 0\\.035766397987973785\ \(0\)\
\-\ presentation\\:\\ 0\\.035040483743941454\ \(0\)\
\-\ week\\:\\ 0\\.03454780259914557\ \(0\)\
\-\ month\\:\\ 0\\.030519220723816777\ \(0\)\
\-\ focal\\:\\ 0\\.029053495287361928\ \(0\)\
\-\ carcinoma\\:\\ 0\\.028832472262093647\ \(0\)\
\-\ mass\\:\\ 0\\.02829669064160868\ \(0\)\
\-\ months\\:\\ 0\\.02778501541297699\ \(0\)\
\-\ 1\\:\\ 0\\.024206266285234604\ \(0\)\
\-\ contrast\\:\\ 0\\.02277113912866554\ \(0\)\
\-\ large\\:\\ 0\\.022244552759893805\ \(0\)\
\-\ findings\\:\\ 0\\.021652820664166184\ \(0\)\
\-\ after\\:\\ 0\\.021047633364395267\ \(0\)\
\-\ for\\:\\ 0\\.01735971782482655\ \(0\)\
\-\ right\\:\\ 0\\.010733710822743055\ \(0\)\
\-\ old\\:\\ 0\\.010415888057883982\ \(0\)\
\-\ patient\\:\\ 0\\.010197522987099856\ \(0\)\
\-\ to\\:\\ 0\\.010168288296261577\ \(0\)\
\-\ \\(\\:\\ 0\\.008599544360045959\ \(0\)\
\-\ \\)\\:\\ 0\\.008494496334682203\ \(0\)\
\-\ with\\:\\ 0\\.004178720574638919\ \(0\)\
\-\ \\,\\:\\ 0\\.003222738875205802\ \(0\)\
\-\ and\\:\\ 0\\.0021429643539549815\ \(0\)\
\-\ \\.\\:\\ 0\\.001267840574905224\ \(0\)\
